Latest News
Update on Mounjaro® (Tirzepatide) – 23rd June 2025
From 23 June 2025, some patients living with obesity and four or more diagnosed health conditions may be eligible for weight-loss support with Mounjaro® (tirzepatide) through their GP.
This will be managed by the practice contacting eligible patients directly. Prescriptions will not be given immediately, and we kindly ask patients not to call the practice about this. We will be in touch over the coming weeks with those who qualify.
Access to Mounjaro will only be available alongside support for healthy eating and physical activity, as part of a wider national programme. Patients must engage with this support service to receive the medication.
To qualify, you must have:
You can also read:
Thank you for your understanding.